BIDDLE WARNER WESTON (Chief Executive Officer) received a stock award from KYVERNA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/17/2026ACC: 0001193125-26-110920
DirectorOfficer· Chief Executive Officer
Since Sep 2024
+408K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
408K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+58K
Price / share
—
Trade value
—
% of position
New position
3/13/2026
0.00→58K
Total
Net shares
+58K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2026 | A · Award | +58K | — | — | New position | 0.00 | 58K |
| Total | +58K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
350K shares
Shares
+350K
Strike price
8.95
Held after
350K
Exercisable
—
3/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock350K shares | 3/13/2026 | A · Award | +350K | 8.95 | — | 350K |